Autopsy report · NCT02097732

Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

“Study halted prematurely due to a change in the standard of care treatment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 years 3 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Michigan Rogel Cancer Center

Sponsor type

University, hospital or other

Conditions

Metastatic Melanoma; Brain Metastases

Interventions

Ipilimumab; Stereotactic Radiosurgery

Participants

4

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.